LBF20107PG11: Difference between revisions
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
|LipidBank=XPR1737 | |LipidBank=XPR1737 | ||
|LipidMaps=LMFA03010055 | |LipidMaps=LMFA03010055 | ||
|SysName= 9- | |SysName= 9-Oxo-11alpha,15R-dihydroxy-prost-13E-en-1-oic acid | ||
|Common Name=&&15 (R) -Prostaglandin E_1&& | |Common Name=&&15(R) -Prostaglandin E_1&& | ||
|Source= | |Source= | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
Revision as of 03:45, 20 April 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1737 |
| LipidMaps | LMFA03010055 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20107PG11 |
| 15(R) -Prostaglandin E1 | |
|---|---|
| |
| Structural Information | |
| 9-Oxo-11α,15R-dihydroxy-prost-13E-en-1-oic acid | |
| |
| Formula | C20H34O5 |
| Exact Mass | 354.240624198 |
| Average Mass | 354.48096000000004 |
| SMILES | C(CC[C@H](O)C=C[C@H]([C@H]1CCCCCCC(O)=O)[C@@H](CC1=O)O)CC |
| Physicochemical Information | |
| 15(R)-Prostaglandin E1 dosen't have biological significance but inhibit 15-hydroxy PGDH (IC50 value of 189 mu M). Jarabak_J et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
